Development, Evaluation, and Clinical Application of PRRSV-2 Vaccine-like Real-Time RT-PCR Assays
- PMID: 38005917
- PMCID: PMC10675446
- DOI: 10.3390/v15112240
Development, Evaluation, and Clinical Application of PRRSV-2 Vaccine-like Real-Time RT-PCR Assays
Abstract
In this study, we developed and validated (1) singleplex real-time RT-PCR assays for specific detection of five PRRSV-2 MLV vaccine viruses (Ingelvac MLV, Ingelvac ATP, Fostera, Prime Pac, and Prevacent) and (2) a four-plex real-time RT-PCR assay (IngelvacMLV/Fostera/Prevacent/XIPC) including the internal positive control XIPC for detecting and distinguishing the three most commonly used vaccines in the USA (Prevacent, Ingelvac MLV, and Fostera). The singleplex and 4-plex vaccine-like PCRs and the reference PCR (VetMAXTM PRRSV NA&EU, Thermo Fisher Scientific, Waltham, MA, USA) did not cross-react with non-PRRSV swine viral and bacterial pathogens. The limits of detection of vaccine-like PCRs ranged from 25 to 50 genomic copies/reactions. The vaccine-like PCRs all had excellent intra-assay and inter-assay repeatability. Based on the testing of 531 clinical samples and in comparison to the reference PCR, the diagnostic sensitivity, specificity, and agreement were in the respective range of 94.67-100%, 100%, and 97.78-100% for singleplex PCRs and 94.94-100%, 100%, and 97.78-100% for the 4-plex PCR, with a CT cutoff of 37. In addition, 45 PRRSV-2 isolates representing different genetic lineages/sublineages were tested with the vaccine-like PCRs and the results were verified with sequencing. In summary, the vaccine-like PCRs specifically detect the respective vaccine-like viruses with comparable performances to the reference PCR, and the 4-plex PCR allows to simultaneously detect and differentiate the three most commonly used vaccine viruses in the same sample. PRRSV-2 vaccine-like PCRs provide an additional tool for detecting and characterizing PRRSV-2.
Keywords: PRRSV; multiplex; porcine reproductive and respiratory syndrome virus; real-time RT-PCR; recombination; singleplex; vaccine-like.
Conflict of interest statement
The authors declare no conflict of interest.
Figures

Similar articles
-
Development and validation of a reverse transcription real-time PCR assay for specific detection of PRRSGard vaccine-like virus.Transbound Emerg Dis. 2022 May;69(3):1212-1226. doi: 10.1111/tbed.14084. Epub 2021 Apr 27. Transbound Emerg Dis. 2022. PMID: 33763963
-
Development of a bead-based assay for detection and differentiation of field strains and four vaccine strains of type 2 porcine reproductive and respiratory syndrome virus (PRRSV-2) in the USA.Transbound Emerg Dis. 2021 May;68(3):1414-1423. doi: 10.1111/tbed.13808. Epub 2020 Sep 8. Transbound Emerg Dis. 2021. PMID: 32816334 Free PMC article.
-
Development of universal and quadruplex real-time RT-PCR assays for simultaneous detection and differentiation of porcine reproductive and respiratory syndrome viruses.Transbound Emerg Dis. 2019 Nov;66(6):2271-2278. doi: 10.1111/tbed.13276. Epub 2019 Jul 7. Transbound Emerg Dis. 2019. PMID: 31233656
-
Cell-mediated immune response and protective efficacy of porcine reproductive and respiratory syndrome virus modified-live vaccines against co-challenge with PRRSV-1 and PRRSV-2.Sci Rep. 2020 Feb 3;10(1):1649. doi: 10.1038/s41598-020-58626-y. Sci Rep. 2020. PMID: 32015495 Free PMC article.
-
Live porcine reproductive and respiratory syndrome virus vaccines: Current status and future direction.Vaccine. 2015 Aug 7;33(33):4069-80. doi: 10.1016/j.vaccine.2015.06.092. Epub 2015 Jul 4. Vaccine. 2015. PMID: 26148878 Review.
Cited by
-
Emergence of a PRRSV Strain Recombined From Two Modified-Live Virus Vaccines and Its Elimination From a Breeding Herd.Transbound Emerg Dis. 2025 Jul 20;2025:5770608. doi: 10.1155/tbed/5770608. eCollection 2025. Transbound Emerg Dis. 2025. PMID: 40727310 Free PMC article.
-
Challenges and Lessons Learned from a Field Trial on the Understanding of the Porcine Respiratory Disease Complex.Vaccines (Basel). 2025 Jul 9;13(7):740. doi: 10.3390/vaccines13070740. Vaccines (Basel). 2025. PMID: 40733717 Free PMC article.
-
Strategies and scheming: the war between PRRSV and host cells.Virol J. 2025 Jun 11;22(1):191. doi: 10.1186/s12985-025-02685-y. Virol J. 2025. PMID: 40500743 Free PMC article. Review.
References
-
- Fang Y., Treffers E.E., Li Y., Tas A., Sun Z., van der Meer Y., de Ru A.H., van Veelen P.A., Atkins J.F., Snijder E.J., et al. Efficient -2 frameshifting by mammalian ribosomes to synthesize an additional arterivirus protein. Proc. Natl. Acad. Sci. USA. 2012;109:E2920–E2928. doi: 10.1073/pnas.1211145109. - DOI - PMC - PubMed
-
- Zimmerman J., Dee S., Holtkamp D.J., Murtaugh M., Stadejek T., Stevenson G., Torremorell M., Yang H., Zhang J. Diseases of Swine. 11th ed. John Wiley & Sons, Inc.; Hoboken, NJ, USA: 2019. Porcine Reproductive and Respiratory Syndrome Viruses (Porcine Arteriviruses) pp. 685–708.
-
- Holtkamp D.J., Kliebenstein J.B., Neumann E.J., Zimmerman J., Rotto H., Yoder T., Wang C., Yeske P., Mowrer C., Haley C. Assessment of the economic impact of porcine reproductive and respiratory syndrome virus on United States pork producers. J. Swine Health Prod. 2013;21:72–84.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources